LivaNova (LIVN) Divestments (2018 - 2021)

LivaNova's (LIVN) quarterly Divestments came in at $2.7 million in Q4 2021, up 278.28% quarter-over-quarter from -$1.5 million in Q3 2021.

Analysis

LivaNova (LIVN) Divestments (2018 - 2021) Analysis & Trends

LivaNova has disclosed Divestments across 2 years of filings, most recently posting $2.7 million for Q4 2021.

In Q4 2021, Divestments changed N/A year-over-year to $2.7 million; the TTM figure through Dec 2022 stood at $1.2 million (down 94.02% YoY), while the FY2021 annual figure was $42.9 million, changed N/A from the prior year.
Divestments came in at $2.7 million for Q4 2021 at LivaNova, up from -$1.5 million in the prior quarter.
In the past five years, Divestments ranged from a high of $173.4 million in Q2 2018 to a low of -$1.5 million in Q3 2021.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	-
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	-
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	-
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	-
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	-
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	-
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	-
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	-
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	-
10	LivaNova	4.34 Bn	3.82 Bn	273.67 Mn	-

Historic Data

Download Data